Senate confirms a permanent FDA commissioner by Q4 2026

Industry pressure and bipartisan support for regulatory stability increase the likelihood of a Senate-confirmed FDA commissioner by December 2026. The current acting commissioner’s interim status lacks long-term authority, raising approval delays for new drugs.

Implied probability (Yes)

70%